Bridgebio Oncology Therapeutics Inc Revenue per Employee (BBOT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bridgebio Oncology Therapeutics Inc   (NASDAQ: BBOT)
 

Bridgebio Oncology Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Bridgebio Oncology Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 166,163, but the productivity of Bridgebio Oncology Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 427 other companies have achieved higher revenue per employee. While Bridgebio Oncology Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1 to 3162. Bridgebio Oncology Therapeutics Inc has 92 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BBOT Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - 161208.79 % - 114700 % -
Sales per Employee (TTM) $ 166,163 166,176 123,333 37,474 72
BBOT's Total Ranking # 3162 # 1 # 0 # 0 #
Seq. Revenue Change - -50.07 % 129.36 % 297052.72 % -52.6 %

BBOT Company Profile >> Back to BBOT Efficiency Comparisons >> Compare BBOT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 157
Healthcare Sector # 428
Overall Market # 3162

Revenue per Employee Statistics
High Average Low
$ 166,176 $ 108,981 $ 37,435
(Mar 31 2026)   (Sep 30 2025)



Financial Statements
Bridgebio Oncology Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit BBOT's Income Statement
Bridgebio Oncology Therapeutics Inc 's Revenues TTM $ 15 Millions Visit BBOT's aggregate revenue growth
What are BBOT's Sales? Visit BBOT's Sales by Segment




Other Ratios
Bridgebio Oncology Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BBOT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BBOT's Competitors
Revenue per Employee for BBOT's Suppliers
Revenue per Employee for BBOT's Customers

You may also want to know
BBOT's Sales Growth Rates BBOT's Pe Price to earnings ratio BBOT's Receivables Turnover Ratio BBOT's Stock Quote
BBOT's Net Income Growth Rates BBOT's Ps Price to Sales ratio BBOT's Sales per Employee BBOT's Asset Turnover Ratio
BBOT's Net Margin BBOT's Pb Price to Book ratio BBOT's Financial Strength Ratios BBOT's Dividend Payout Ratio
Date modified: 2026-09-05T00:01:33+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Becton Dickinson And Company  289,444.44 $ 20,840.000  Million 72,000 
International Stem Cell Corporation  288,303.03 $ 9.514  Million 33 
Radnet Inc   288,228.15 $ 2,268.932  Million 7,872 
Beta Bionics Inc   284,554.76 $ 119.513  Million 420 
Vaso Corporation  284,468.09 $ 80.220  Million 282 
Prelude Therapeutics Inc  283,848.10 $ 22.424  Million 79 
Champions Oncology Inc   283,467.29 $ 60.662  Million 214 
Apyx Medical Corp  283,439.02 $ 58.105  Million 205 
The Cooper Companies Inc   282,440.00 $ 4,236.600  Million 15,000 
Rxsight Inc   277,069.41 $ 127.729  Million 461 
Cytosorbents Corporation  276,455.52 $ 35.663  Million 129 
Cv Sciences Inc   274,227.27 $ 12.066  Million 44 
Cadre Holdings inc   271,038.29 $ 686.540  Million 2,533 
Cvrx inc   269,793.72 $ 60.164  Million 223 
Lifeward ltd   269,407.41 $ 21.822  Million 81 
Personalis Inc   267,957.69 $ 69.669  Million 260 
Cytomx Therapeutics Inc   265,246.38 $ 18.302  Million 69 
Revvity Inc  264,710.09 $ 2,911.811  Million 11,000 
Arcturus Therapeutics Holdings Inc   264,576.58 $ 29.368  Million 111 
Innovative Eyewear Inc   262,462.92 $ 3.412  Million 13 
Surrozen Inc   261,613.64 $ 11.511  Million 44 
Dentsply Sirona Inc   260,214.29 $ 3,643.000  Million 14,000 
Harvard Bioscience Inc   260,070.80 $ 88.164  Million 339 
Opko Health Inc   258,415.82 $ 587.896  Million 2,275 
Vycor Medical Inc   258,210.43 $ 1.807  Million 7 
Wave Life Sciences Ltd   257,873.82 $ 81.746  Million 317 
Zomedica Corp   254,631.21 $ 35.903  Million 141 
Ardent Health Inc   254,203.97 $ 6,405.940  Million 25,200 
Rosecliff Acquisition Corp I  253,338.46 $ 16.467  Million 65 
Cryoport inc   252,644.99 $ 186.452  Million 738 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.